Know Cancer

or
forgot password


Phase 4
45 Years
90 Years
Open (Enrolling by invite only)
Both
Chronic Lymphocytic Leukemia (CLL)

Thank you

Trial Information


Inclusion Criteria:



- CLL patients and controls who have been vaccinated with PCV in our previous study

Exclusion Criteria:

- Vaccinated with PPV-vaccine within the last 5 years, immunoglobulin substitution,
corticosteroid treatment (equivalent of 20mg prednisolone per day)

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Antibody response

Outcome Time Frame:

1-3 months

Safety Issue:

Yes

Authority:

Finland: Finnish Medicines Agency

Study ID:

R09082M

NCT ID:

NCT00919321

Start Date:

June 2009

Completion Date:

December 2012

Related Keywords:

  • Chronic Lymphocytic Leukemia (CLL)
  • CLL
  • PPV
  • PCV
  • Leukemia
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Lymphoid

Name

Location